Valuation (43%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 16.93 | N/A |
PEG Ratio (TTM) | 3.06 | N/A |
P/S Ratio (TTM) | 0.90 | N/A |
P/B Ratio (TTM) | 2.76 | N/A |
P/FCF Ratio (TTM) | -26.55 | N/A |
Price to 5YR AVG Earnings Ratio | 86.75 | N/A |
Price to 5YR AVG FCF Ratio | -6.53 | N/A |
Profitability (28%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.95% | N/A |
ROE (TTM) | 16.37% | N/A |
Net Profit Margin (TTM) | 5.31% | N/A |
ROIC 5YR AVG | 1.51% | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 52.00% | -54.42% | 11.05% |
Revenue | -0.63% | -12.63% | 8.69% |
Net Income | 53.27% | -53.52% | -0.35% |
Cash Flow | 68.82% | 21.09% | 474.11% |
Health (44%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.18 | N/A |
Quick Ratio (TTM) | 1.26 | N/A |
D/E Ratio (TTM) | 5.39 | N/A |
Interest Coverage (TTM) | 1.81 | N/A |
Piotroski F-Score | 6 | N/A |
Altman Z-Score | 1.05 | N/A |
LTL to 5YR AVG FCF | -13.16 | N/A |
Shares Outstanding Growth 5YR AVG | -10.62% | N/A |